DNA repair defects and implications for immunotherapy

被引:66
作者
Bever, Katherine M. [1 ]
Le, Dung T. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
关键词
TUMOR-INFILTRATING LYMPHOCYTES; SQUAMOUS-CELL CARCINOMA; COLORECTAL-CANCER; PD-1; BLOCKADE; XERODERMA-PIGMENTOSUM; MICROSATELLITE INSTABILITY; CHECKPOINT BLOCKADE; CLINICAL-RESPONSE; IMMUNE-RESPONSE; CTLA-4;
D O I
10.1172/JCI122010
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A complex DNA repair machinery has evolved to protect genomic integrity in the face of a myriad of DNA damage sources. When DNA repair fails, this damage can lead to carcinogenesis and tumor genomic instability. Indeed, many heritable cancer predisposition syndromes are attributable to germline defects in DNA repair pathways. On the other hand, these defects may also portend particular vulnerabilities of the cancer and may be exploited therapeutically. Most recently this has been demonstrated in the case of mismatch repair-deficient cancers, in which the immune checkpoint inhibitors have been demonstrated to be highly active. This observation has paved the way for further research investigating other sources of genomic instability that may serve as biomarkers to select patients for immunotherapy.
引用
收藏
页码:4236 / 4242
页数:7
相关论文
共 87 条
[1]   New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31st Annual Meeting of the Society for Immunotherapy of Cancer, 2016 [J].
Adusumilli, Prasad S. ;
Cha, Edward ;
Cornfeld, Mark ;
Davis, Thomas ;
Diab, Adi ;
Dubensky, Thomas W., Jr. ;
Evans, Elizabeth ;
Grogan, Jane L. ;
Irving, Bryan A. ;
Leidner, Rom S. ;
Olwill, Shane A. ;
Soon-Shiong, Patrick ;
Triebel, Frederic ;
Tuck, David ;
Bot, Adrian ;
Dansey, Roger D. ;
Drake, Charles G. ;
Freeman, Gordon J. ;
Ibrahim, Ramy ;
Patel, Salil ;
Chen, Daniel S. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[2]   Excision repair cross complementation group 1 (ERCC-1) gene polymorphisms and response to nivolumab in advanced non-small cell lung cancer (NSCLC). [J].
Aiello, Marco M. ;
Vigneri, Paolo Giovanni ;
Bruzzi, Paolo ;
Verderame, Francesco ;
Paratore, Sabrina ;
Restuccia, Nunzio ;
Albanese, Valeria ;
Parra, Hector J. Soto .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[3]   Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer [J].
Anagnostou, Valsamo ;
Smith, Kellie N. ;
Forde, Patrick M. ;
Niknafs, Noushin ;
Bhattacharya, Rohit ;
White, James ;
Zhang, Theresa ;
Adleff, Vilmos ;
Phallen, Jillian ;
Wali, Neha ;
Hruban, Carolyn ;
Guthrie, Violeta B. ;
Rodgers, Kristen ;
Naidoo, Jarushka ;
Kang, Hyunseok ;
Sharfman, William ;
Georgiades, Christos ;
Verde, Franco ;
Illei, Peter ;
Li, Qing Kay ;
Gabrielson, Edward ;
Brock, Malcolm V. ;
Zahnow, Cynthia A. ;
Baylin, Stephen B. ;
Scharpf, Robert B. ;
Brahmer, Julie R. ;
Karchin, Rachel ;
Pardoll, Drew M. ;
Velculescu, Victor E. .
CANCER DISCOVERY, 2017, 7 (03) :264-276
[4]   IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade [J].
Ayers, Mark ;
Lunceford, Jared ;
Nebozhyn, Michael ;
Murphy, Erin ;
Loboda, Andrey ;
Kaufman, David R. ;
Albright, Andrew ;
Cheng, Jonathan D. ;
Kang, S. Peter ;
Shankaran, Veena ;
Piha-Paul, Sarina A. ;
Yearley, Jennifer ;
Seiwert, Tanguy Y. ;
Ribas, Antoni ;
McClanahan, Terrill K. .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (08) :2930-2940
[5]   Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer [J].
Balachandran, Vinod P. ;
Luksza, Marta ;
Zhao, Julia N. ;
Makarov, Vladimir ;
Moral, John Alec ;
Remark, Romain ;
Herbst, Brian ;
Askan, Gokce ;
Bhanot, Umesh ;
Senbabaoglu, Yasin ;
Wells, Daniel K. ;
Cary, Charles Ian Ormsby ;
Grbovic-Huezo, Olivera ;
Attiyeh, Marc ;
Medina, Benjamin ;
Zhang, Jennifer ;
Loo, Jennifer ;
Saglimbeni, Joseph ;
Abu-Akeel, Mohsen ;
Zappasodi, Roberta ;
Riaz, Nadeem ;
Smoragiewicz, Martin ;
Kelley, Z. Larkin ;
Basturk, Olca ;
Goenen, Mithat ;
Levine, Arnold J. ;
Allen, Peter J. ;
Fearon, Douglas T. ;
Merad, Miriam ;
Gnjatic, Sacha ;
Iacobuzio-Donahue, Christine A. ;
Wolchok, Jedd D. ;
DeMatteo, Ronald P. ;
Chan, Timothy A. ;
Greenbaum, Benjamin D. ;
Merghoub, Taha ;
Leach, Steven D. .
NATURE, 2017, 551 (7681) :512-+
[6]   High expression of PD-1 ligands is associated with kataegis mutational signature and APOBEC3 alterations [J].
Boichard, Amelie ;
Tsigelny, Igor F. ;
Kurzrock, Razelle .
ONCOIMMUNOLOGY, 2017, 6 (03)
[7]   Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival [J].
Brown, Scott D. ;
Warren, Rene L. ;
Gibb, Ewan A. ;
Martin, Spencer D. ;
Spinelli, John J. ;
Nelson, Brad H. ;
Holt, Robert A. .
GENOME RESEARCH, 2014, 24 (05) :743-750
[8]   Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1 [J].
Buchanan, Daniel D. ;
Stewart, Jenna R. ;
Clendenning, Mark ;
Rosty, Christophe ;
Mahmood, Khalid ;
Pope, Bernard J. ;
Jenkins, Mark A. ;
Hopper, John L. ;
Southey, Melissa C. ;
Macrae, Finlay A. ;
Winship, Ingrid M. ;
Win, Aung Ko .
GENETICS IN MEDICINE, 2018, 20 (08) :890-895
[9]   Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers [J].
Carbognin, Luisa ;
Pilotto, Sara ;
Milella, Michele ;
Vaccaro, Vanja ;
Brunelli, Matteo ;
Calio, Anna ;
Cuppone, Federica ;
Sperduti, Isabella ;
Giannarelli, Diana ;
Chilosi, Marco ;
Bronte, Vincenzo ;
Scarpa, Aldo ;
Bria, Emilio ;
Tortora, Giampaolo .
PLOS ONE, 2015, 10 (06)
[10]   First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer [J].
Carbone, D. P. ;
Reck, M. ;
Paz-Ares, L. ;
Creelan, B. ;
Horn, L. ;
Steins, M. ;
Felip, E. ;
van den Heuvel, M. M. ;
Ciuleanu, T. -E. ;
Badin, F. ;
Ready, N. ;
Hiltermann, T. J. N. ;
Nair, S. ;
Juergens, R. ;
Peters, S. ;
Minenza, E. ;
Wrangle, J. M. ;
Rodriguez-Abreu, D. ;
Borghaei, H. ;
Blumenschein, G. R. ;
Villaruz, L. C. ;
Havel, L. ;
Krejci, J. ;
Corral Jaime, J. ;
Chang, H. ;
Geese, W. J. ;
Bhagavatheeswaran, P. ;
Chen, A. C. ;
Socinski, M. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (25) :2415-2426